Target intelligence / Profile preview

Immunoglobulin heavy variable 3-41 (IGHV3-41)

Target
IGHV3-41
Molecular classification
Immunoglobulin gene segment, Pseudogene, Other
01

Overview

Immunoglobulin heavy variable 3-41 (IGHV3-41) is a gene segment within the immunoglobulin heavy-chain locus, contributing to the diversity of antigen receptors in B lymphocytes. It encodes part of the variable region of the immunoglobulin heavy chain, which, through V(D)J recombination, enables the immune system to recognize a vast array of antigens[1]. This segment may be annotated as a pseudogene, indicating it is generally not expressed as a functional protein. The locus undergoes complex genomic rearrangements during B cell development, permitting antibody diversity essential for humoral immunity. Specific information regarding IGHV3-41 itself is sparse, with some databases listing it as a pseudogene and others lacking functional or disease associations[2]. There are no known drugs that directly interact with IGHV3-41, as it is not a protein with typical druggable properties. It is not a recognized biomarker individually, and as a gene segment or pseudogene, it has no direct therapeutic safety profile. Information on IGHV3-41 as a unique, functional protein or therapeutic target is not available in major genetic or protein databases. It is best understood as a segment (possibly inactive) in the immunoglobulin heavy chain locus, important for genetic recombination and antibody diversity, but not as a standalone drug target, receptor, or biomarker[1][2]. If you seek therapeutic targets, consider full immunoglobulin complexes or specific membrane-bound receptors instead.

Other names
3-41PIGHV341IGHV3-41
02

Mechanism of action

None applicable. Drugs do not target this gene segment directly.

03

Biological functions

Generation of antibody diversityAntigen recognition (via its encoded variable region in immunoglobulin heavy chains)Immune response (humoral immunity)
04

Disease associations

Germline variation in IGHV genes can influence susceptibility to infection, autoimmune conditions, and potentially cancer, though there's no specific evidence for IGHV3-41 itselfOther (as part of immunoglobulin gene rearrangements)

Beyond the preview

Go deeper on Immunoglobulin heavy variable 3-41 (IGHV3-41).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 3-41 (IGHV3-41).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call